BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 16573551)

  • 1. EBV-associated recurrent Hodgkin's disease after renal transplantation.
    Flanagan KH; Brennan DC
    Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
    Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
    Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-transplantation of Hodgkin's disease. Clinico-pathologic study of 3 cases].
    Moreau A; Dantal J; Heymann MF; Gaillard F; Dubigeon P; Portier D; Moreau P; Milpied N; Laboisse C
    Ann Pathol; 1996; 16(2):124-7. PubMed ID: 8767681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
    Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
    Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and consequences of post-transplantation lymphoproliferative disorders.
    Boubenider S; Hiesse C; Goupy C; Kriaa F; Marchand S; Charpentier B
    J Nephrol; 1997; 10(3):136-45. PubMed ID: 9238621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P
    Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr virus-associated posttransplant lymphoproliferative disease after renal transplantation].
    Matsubara E; Yakushijin Y; Nomura T; Iwamasa K; Narumi H; Sakai I; Yasukawa M; Fujita S; Hato T; Ohshima K; Uno M
    Rinsho Ketsueki; 2002 Oct; 43(10):949-53. PubMed ID: 12462032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.
    Stern M; Herrmann R; Rochlitz C; Dirnhofer S; Pless M
    Eur J Haematol; 2005 Mar; 74(3):267-70. PubMed ID: 15693799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.
    Yufu Y; Kimura M; Kawano R; Noguchi Y; Takatsuki H; Uike N; Ohshima K
    Bone Marrow Transplant; 2000 Dec; 26(12):1339-41. PubMed ID: 11223975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
    Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
    Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.